NEW YORK, NY--(Marketwire - September 19, 2008) - Delcath Systems, Inc. (NASDAQ: DCTH), a leading developer of regional therapy for cancer, today announced that Dr. Charles Nutting of Swedish Medical Center in Englewood, Colorado will deliver a presentation at the 38th Annual Meeting of the Western Angiographic and Interventional Society (“WAIS”). Dr. Nutting will discuss his involvement with Delcath’s Phase III trial of its Percutaneous Hepatic Perfusion (PHP) System for the treatment of inoperable metastatic melanoma at the conference, held in Maui, Hawaii from September 20-25, 2008.
